feed,title,long_url,short_url
MedRxiv,"Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study",https://medrxiv.org/cgi/content/short/2025.06.09.25329141v1?rss=1,https://da.gd/VPd5gP
